SUBSCRIBE
SUBSCRIBE
News   Business

India’s Nicholas Piramal India Limited In Drug Pact With Eli Lilly and Company

January 12, 2007 | 
1 min read

MUMBAI, Jan 12 (Reuters) - Indian drug maker Nicholas Piramal Ltd. (NICH.BO: Quote, Profile , Research) said on Friday it had reached a drug-development agreement with Eli Lilly and Co. (LLY.N: Quote, Profile , Research).

>>> Discuss This Story

Alliances Asia
MORE ON THIS TOPIC
Hand holding pencil erasing an employee. Dismissal or bankrumptcy concept. Vector illustration.
Layoffs
Eisai Will Trim About 7% of US Workforce, Including New Jersey Employees
February 28, 2025
 · 
1 min read
 · 
Angela Gabriel
Pictured: Eli Lilly's headquarters in Indianapolis
Collaboration
Lilly Hops On Hot Molecular Glue Train With $1.2B+ Magnet Deal
February 28, 2025
 · 
2 min read
 · 
Tristan Manalac
Contemporary art collage of a hand holding scissors. Copy space for ad. Modern design.
Pipeline
Mission Nixes Preclinical Studies, Falls Back on Clinical Candidates
February 28, 2025
 · 
2 min read
 · 
Tristan Manalac
Illustration of two hands shaking while another hand gently grips a wrist
Collaboration
Cassava’s Stock Rises After Licensing Seizure Rights for Embattled Drug Simufilam
February 28, 2025
 · 
2 min read
 · 
Tristan Manalac